Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia

Recruiting

ApremilastTrial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia

Sponsor:

Bellevue Dermatology

Code:

NCT03422640

Conditions

Frontal Fibrosing Alopecia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Apremilast

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-23. This information was provided to ClinicalTrials.gov by Bellevue Dermatology on 2018-07-16.